Burger-Kentischer, AnkeAnkeBurger-KentischerMattes, AngelaAngelaMattesZatsepin, MariaMariaZatsepinGoldblum, AmriamAmriamGoldblum2022-03-082022-03-082016https://publica.fraunhofer.de/handle/publica/310924The present invention relates to a compound or a pharmaceutically acceptable salt thereof or a solvate thereof or a pharmaceutical composition comprising said compound, a process for obtaining or screening for a toll-like receptor 9 (TLR9) antagonist and a toll-like receptor 9 (TLR9) antagonist or a pharmaceutically acceptable salt thereof or a solvate thereof, preferably being obtainable thereby.en660patent2016151085